Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 4, 2000, Pages 565-570

  Rastogi, N ^a   Goh, K S ^a   Berchel, M ^a   Bryskier, A ^b,c  

^a Unite de la Tuberculose et des Mycobacteries   (Guadeloupe)

^b SANOFI   (France)

^c CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

25 O DESACETYLRIFAPENTINE; BCG VACCINE; DRUG METABOLITE; RIFABUTIN; RIFAMPICIN; RIFAPENTINE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RADIOMETRY;

EID: 0033793950     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.4.565     Document Type: Article

References (24)

1. Single and multiple dose pharmacokinetics of rifapentine in man
2. Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: A phase I study
3. Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics
4. Activite de la rifampicine administree de maniere intermittente et de la cyclopentyl rifamycine (ou DL473) sur la tuberculose experimentale de la souris
5. Development of rifapentine susceptibility tests for Mycobacterium tuberculosis
6. Antimycobacterial activities of two newer ansamysins, R-76-1 and DL473
7. Rifapentine
8. Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice
9. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages
10. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis
11. In vitro activity of roxithromycin against the Mycobacterium tuberculosis complex
12. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British thoracic and tuberculosis association
13. Treatment of tuberculosis and tuberculosis infection in adults and children
14. Current problems with tuberculosis treatment
15. Emergence of multiple drug resistant tuberculosis: Fundamental and applied research aspects, global issues and current strategies
16. FDA approves tuberculosis drug
17. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy
18. Determination of in vitro susceptibility of mycobacteria to ansamycin
19. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin
20. Use of rifabutin in the treatment of pulmonary tuberculosis
21. Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis
22. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis
23. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid: Tuberculosis trials consortium
24. Brief report: Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis